# Postoperative Antibiotics Following Primary and Secondary Breast Augmentation

> **NCT04834310** · PHASE4 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Surgical Site Infection
- Capsular Contracture Associated With Breast Implant
- Antibiotic Resistant Infection
- Antibiotic Side Effect

## Interventions

- **DRUG:** Cefazolin
- **DRUG:** Cephalexin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04834310
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Do not have adequate funding to proceed with project.
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834310, "Postoperative Antibiotics Following Primary and Secondary Breast Augmentation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04834310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*